Endocrinology Medical News about ezetimibe

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Co-administration of ezetimibe and a statin in management of dyslipidemias: a meta-analysis of clinical trials
Archives of Medical Science, 11/02/09

Angelopoulos J et al. – Ezetimibe coadministered with statins is effective in reducing LDL–C in patients who do not attain target LDL–C levels while on statin monotherapy. Simultaneous administration of a statin plus ezetimibe regimen in patients who are treatment–naI¨ve is also efficient at reducing plasma LDL–C.

<< Previous
Hypolipidemic Effect of Fenugreek Seeds Is Mediated Through...

Next >>
Do plasma leptin levels predict diastolic dysfunction in patients...

Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia
Journal of Cardiovascular Pharmacology and Therapeutics, 11/12/09 Relevance Score: 87%

Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia
Lipids in Health and Disease, 10/13/09 Relevance Score: 87%

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09 Relevance Score: 84%

Abbott Statement on ARBITER 6 - HALTS Results and Abbotts Niaspan
Abbott, 11/16/09 Relevance Score: 80%